. 2021 Dec 20;117(2):287–296. doi: 10.1016/j.fertnstert.2021.10.022

Table 3.

Spearman rho correlation of sperm quality parameters in relation to clinical characteristics and immunity parameters of participants in the SpermCOVID study.

Sperm quality	n	Risk factor						Time lapse period		Symptom score		Severity		sIgG-RBD		sIgG-N		sIgG-S1
		Age		BMI		Smoking		Time lapse period		Symptom score		Severity		sIgG-RBD		sIgG-N		sIgG-S1
		r²	P	r²	P	r²	P	r²	P	r²	P	r²	P	r²	P	r²	P	r²	P
Volume	118	–.238	.009	–.111	.2	.065	.5	.019	.8	.001	1	–.04	.7	.131	.6	.064	.5	.107	.3
pH	118	–.01	.9	–.007	.9	–.059	.5	–.1	.3	–.025	.8	–.041	.7	.218	.018	.155	.11	.204	.028
Total no. of sperm cells	118	–.097	.4	–.094	.4	.072	.5	.26	.009	–.047	.6	–.101	.3	–.17	.09	–.168	.11	–.157	.12
Sperm concentration	118	–.091	.3	–.004	1	.074	.4	.257	.005	–.034	.7	–.101	.3	–.259	.005	–.253	.008	–.25	.007
Total mobility count	118	–.164	.076	.061	.5	–.055	.6	.247	.007	–.032	.7	–.196	.033	–.234	.011	–.185	.56	–.188	.043
Progressive mobility	118	–.194	.035	.106	.3	–.029	.8	.252	.006	–.087	.3	–.206	.025	–.236	.011	–.214	.27	–.185	.045
% ideal forms	118	–.15	.11	.023	.8	–.072	.4	.094	.3	–.05	.6	–.195	.034	–.177	.057	–.152	.12	–.161	.083
OAT severity	118	.123	.2	.68	.5	.084	.4	–.226	.014	.078	.4	1	.28	.287	.002	.26	.005	.314	.001
MAR IgG	114	–.009	.9	.011	.9	–.133	.16	.138	.014	–.056	.6	–.059	.5	.148	.12	.004	1	.151	.11
MAR IgA	106	.016	.9	–.112	.3	.042	.7	.11	.014	–.066	.5	–.025	.8	.055	.6	–.126	.2	–1.06	.28
HDS	118	–.185	.044	–.145	.12	–.07	.4	–.195	.014	–.132	.45	.126	.2	.21	.021	.064	.5	.21	.023
DFI	118	.218	.018	.073	.4	–.035	.7	–.032	.014	–.006	1	.179	.052	.34	.0001	.108	.3	.289	.002

Note: BMI = body mass index; DFI = DNA fragmentation index; HDS = high DNA stainability; MAR = mixed erythrocyte-spermatozoa antiglobulin reaction; OAT = oligo-astheno-teratozoospermia; sIgG-N = serum immune globulin G (sIgG) aginst the nucleotide; sIgG-RBD = sIgG aginst the receptor domain of S1; sIgG–S1 = SIgG against the antigen S1.